Today on HITshow:
Todayโs top story: the federal shutdown is more than politics โ Teresa Vaughn walks providers through a detailed checklist on compliance, telehealth, hospital-at-home, finance, and research. Also: UnitedHealth hires Dukeโs AI leader as Chief Scientist, Hackensack pairs dogs with AI for cancer detection, Omada launches a nutrition AI for chronic care, and the federal government calls on Eli Lilly and Pfizer to boost production of key drugs.
HOST: Steve Daily
๐ Providers / Government โ Teresa VaughnThe shutdown fallout is hitting operations: CMS survey triage, telehealth flex expirations, Hospital-at-Home pause, and looming safety-net cuts. Vaughn shares the following checklist for health system leaders:
Quality & Compliance: Focus on IJ, EMTALA, dialysis.
Access & Scheduling: Update telehealth workflows for therapy and mental health.
Capacity: Reallocate staff and beds with Hospital-at-Home paused.
Finance: Model DSH and rural add-on reductions through Q4.
Community: Coordinate with FQHCs to smooth referrals.
Innovation & Research: Expect device and grant delays; adjust timelines.
๐ AI & Payers โ Jade RomeroUnitedHealth names Dukeโs Michael Pencina as Chief AI Scientist, signaling a credibility-first push to scale responsible AI.
๐ Providers / Research โ Logan StokesHackensack Meridian partners with Israel-based startup SpotitEarly to validate canine scent + AI for early cancer detection โ a message to providers that bold research can be a differentiator.
๐ Digital Health โ Nate CollierOmada Health debuts โMeal Map,โ an AI nutrition tool for cardiometabolic patients โ early pilots show engagement gains.
๐ Pharma & Policy โ Peter BetterworthThe administration asks Eli Lilly to ramp production of insulin, and Pfizer to increase productoin of Ibrance, and Lipitor โ raising supply and formulary planning questions for hospitals.
๐ง Subscribe here or wherever you listen to podcasts, and if you like our show, please follow us on LinkedIn at https://www.linkedin.com/company/hit.show.
HITshow is made possible by HLTH 2025.